Pharmacyclics, Inc. (PCYC) Posts Wider than Expected Q4 Loss
Tweet
Share
E-mailGet Alerts PCYC Hot Sheet
Price: $261.25 --0%
Financial Fact:
Total revenues: 205.77M
Today's EPS Names:
FRMM, PETS, DARE, More
Financial Fact:
Total revenues: 205.77M
Today's EPS Names:
FRMM, PETS, DARE, More
Join SI Premium – FREE
Pharmacyclics, Inc. (NASDAQ: PCYC) reported Q4 non-GAAP loss of ($0.15), versus the analyst estimate of ($0.14). Revenue for the quarter came in at $1.39 million versus the consensus estimate of $2.67 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- Aptera Motors (SEV) Reports Q2 Loss of $0.20
- Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q2 EPS; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
